 |
 |

Trends in the Use of Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defect in Adults, 1998-2004
 |
 |
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
 |
 |
To the Editor: Percutaneous closure of patent foramen ovale/atrial septal defect (PFO/ASD) is perceived as having minimal risk and has been proposed for a broad array of indications.1 The widespread application of this procedure, especially PFO closure, is controversial because of limited data on its efficacy and safety in many settings, including prevention of recurrent cryptogenic stroke.2 We studied trends in the prevalence of PFO/ASD closure in the United States.
Methods
We analyzed data from 1998 through 2004 of the Nationwide Inpatient Sample, the largest publicly available all-payer US inpatient database; this stratified sample approximates a 20% sample of US community hospitals. The Hospital of the University of Pennsylvania institutional review board granted an exemption for this study.
The cohort included participants aged 20 years or older with a procedure code from the International Classification of Diseases, Ninth Revision (ICD-9) designating "Repair of ASD with prosthesis, closed technique" (. . . [Full Text of this Article]
Alexander R. Opotowsky, MD, MPH
alexander.opotowsky@uphs.upenn.edu Department of Medicine University of Pennsylvania Medical Center Philadelphia
Michael J. Landzberg, MD
Department of Medicine Brigham and Women's Hospital Boston, Massachusetts
Stephen E. Kimmel, MD, MSCE;
Gary D. Webb, MD
Department of Medicine University of Pennsylvania Medical Center Philadelphia
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED LETTERS
Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defect
Ravinay Bhindi and Oliver J. Ormerod
JAMA. 2008;299(19):2272.
EXTRACT
| FULL TEXT
Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defect—Reply
Alexander R. Opotowsky, Michael J. Landzberg, and Gary D. Webb
JAMA. 2008;299(19):2272-2273.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Percutaneous patent foramen ovale/atrial septal defect closure: just because we can?
Opotowsky and Webb
Ann. Thorac. Surg. 2009;88:1386-1386.
FULL TEXT
Trends in hospitalizations for adults with congenital heart disease in the u.s.
Opotowsky et al.
J Am Coll Cardiol 2009;54:460-467.
ABSTRACT
| FULL TEXT
Prevalence and Repair of Intraoperatively Diagnosed Patent Foramen Ovale and Association With Perioperative Outcomes and Long-term Survival
Krasuski et al.
JAMA 2009;302:290-297.
ABSTRACT
| FULL TEXT
Impact of Percutaneous Device Implantation for Closure of Patent Foramen Ovale on Valve Insufficiencies
Wohrle et al.
Circulation 2009;119:3002-3008.
ABSTRACT
| FULL TEXT
Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention: A Call for Completion of Randomized Clinical Trials A Science Advisory From the American Heart Association/American Stroke Association and the American College of Cardiology Foundation The American Academy of Neurology affirms the value of this science advisory
O'Gara et al.
J Am Coll Cardiol 2009;53:2014-2018.
ABSTRACT
| FULL TEXT
Percutaneous Device Closure of Patent Foramen Ovale for Secondary Stroke Prevention: A Call for Completion of Randomized Clinical Trials: A Science Advisory From the American Heart Association/American Stroke Association and the American College of Cardiology Foundation The American Academy of Neurology affirms the value of this science advisory.
O'Gara et al.
Circulation 2009;119:2743-2747.
ABSTRACT
| FULL TEXT
Percutaneous Device Closure of Patent Foramen Ovale in Patients With Presumed Cryptogenic Stroke or Transient Ischemic Attack: The Mayo Clinic Experience
Ford et al.
J Am Coll Cardiol Intv 2009;2:404-411.
ABSTRACT
| FULL TEXT
Patent Foramen Ovale in Cryptogenic Stroke: Not to Close
Messe and Kasner
Circulation 2008;118:1999-2004.
FULL TEXT
Percutaneous Closure of Patent Foramen Ovale and Atrial Septal Defect
Bhindi and Ormerod
JAMA 2008;299:2272-2272.
FULL TEXT
|